$PMDI
PSYCHEMEDICS CORP

2014 Q1 Form 10-Q Financial Statement

#000114420414026766 Filed on May 01, 2014

View on sec.gov

Income Statement

Concept 2014 Q1 2013 Q1
Revenue $7.045M $6.432M
YoY Change 9.53% 3.01%
Cost Of Revenue $3.249M $2.945M
YoY Change 10.32% 14.15%
Gross Profit $3.796M $3.487M
YoY Change 8.86% -4.86%
Gross Profit Margin 53.88% 54.21%
Selling, General & Admin $2.283M $2.120M
YoY Change 7.66% 0.02%
% of Gross Profit 60.14% 60.81%
Research & Development $345.0K $164.7K
YoY Change 109.45% -3.11%
% of Gross Profit 9.09% 4.72%
Depreciation & Amortization $218.0K $207.1K
YoY Change 5.3% 47.9%
% of Gross Profit 5.74% 5.94%
Operating Expenses $2.628M $2.285M
YoY Change 15.0% -0.21%
Operating Profit $1.168M $1.202M
YoY Change -2.83% -12.71%
Interest Expense $252.00 $90.00K
YoY Change -99.72%
% of Operating Profit 0.02% 7.49%
Other Income/Expense, Net $1.549K
YoY Change
Pretax Income $1.170M $1.290M
YoY Change -9.33% -6.52%
Income Tax $413.4K $471.3K
% Of Pretax Income 35.35% 36.53%
Net Earnings $756.0K $822.0K
YoY Change -8.03% -0.6%
Net Earnings / Revenue 10.73% 12.78%
Basic Earnings Per Share $0.14 $0.16
Diluted Earnings Per Share $0.14 $0.16
COMMON SHARES
Basic Shares Outstanding 5.318M shares 5.273M shares
Diluted Shares Outstanding 5.371M shares 5.293M shares

Balance Sheet

Concept 2014 Q1 2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.210M $2.510M
YoY Change -11.95% -46.93%
Cash & Equivalents $2.209M $2.513M
Short-Term Investments
Other Short-Term Assets $1.520M $1.260M
YoY Change 20.63% 20.0%
Inventory
Prepaid Expenses
Receivables $4.819M $4.870M
Other Receivables $210.0K $350.0K
Total Short-Term Assets $8.759M $8.990M
YoY Change -2.57% -15.43%
LONG-TERM ASSETS
Property, Plant & Equipment $8.593M $4.330M
YoY Change 98.46% 103.29%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $672.1K $380.0K
YoY Change 76.87% 46.15%
Total Long-Term Assets $9.266M $4.720M
YoY Change 96.3% 98.32%
TOTAL ASSETS
Total Short-Term Assets $8.759M $8.990M
Total Long-Term Assets $9.266M $4.720M
Total Assets $18.02M $13.71M
YoY Change 31.47% 5.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $778.5K $750.0K
YoY Change 3.81% 25.0%
Accrued Expenses $2.444M $770.0K
YoY Change 217.36% 4.05%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $210.6K
YoY Change
Total Short-Term Liabilities $3.433M $1.530M
YoY Change 124.37% 14.18%
LONG-TERM LIABILITIES
Long-Term Debt $842.4K $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $842.4K $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.433M $1.530M
Total Long-Term Liabilities $842.4K $0.00
Total Liabilities $5.589M $2.340M
YoY Change 138.86% 28.57%
SHAREHOLDERS EQUITY
Retained Earnings -$6.602M
YoY Change
Common Stock $29.12M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $10.08M
YoY Change
Treasury Stock Shares 668.1K shares
Shareholders Equity $12.43M $11.37M
YoY Change
Total Liabilities & Shareholders Equity $18.02M $13.71M
YoY Change 31.47% 5.38%

Cashflow Statement

Concept 2014 Q1 2013 Q1
OPERATING ACTIVITIES
Net Income $756.0K $822.0K
YoY Change -8.03% -0.6%
Depreciation, Depletion And Amortization $218.0K $207.1K
YoY Change 5.3% 47.9%
Cash From Operating Activities -$260.0K $610.0K
YoY Change -142.62% 258.82%
INVESTING ACTIVITIES
Capital Expenditures $1.524M $152.5K
YoY Change 899.56% -176.26%
Acquisitions
YoY Change
Other Investing Activities -$130.0K -$40.00K
YoY Change 225.0% 100.0%
Cash From Investing Activities -$1.810M -$380.0K
YoY Change 376.32% 72.73%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $0.00
YoY Change
Cash From Financing Activities 300.0K -790.0K
YoY Change -137.97% 0.0%
NET CHANGE
Cash From Operating Activities -260.0K 610.0K
Cash From Investing Activities -1.810M -380.0K
Cash From Financing Activities 300.0K -790.0K
Net Change In Cash -1.770M -560.0K
YoY Change 216.07% -33.33%
FREE CASH FLOW
Cash From Operating Activities -$260.0K $610.0K
Capital Expenditures $1.524M $152.5K
Free Cash Flow -$1.784M $457.5K
YoY Change -490.05% 23.65%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3970512 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4368864 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
769269 USD
CY2013Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
554828 USD
CY2013Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
292795 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2958470 USD
CY2014Q1 us-gaap Liabilities Current
LiabilitiesCurrent
3432832 USD
CY2014Q1 us-gaap Treasury Stock Value
TreasuryStockValue
10081789 USD
CY2013Q4 us-gaap Treasury Stock Value
TreasuryStockValue
10081789 USD
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2512665 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
302453 USD
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1761724 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
608901 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-258106 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-785542 USD
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-553120 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3065785 USD
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
105684 USD
CY2013Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
250996 USD
CY2013Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
84808 USD
CY2014Q1 us-gaap Interest Expense
InterestExpense
252 USD
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2208788 USD
CY2014Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4818663 USD
CY2014Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1172688 USD
CY2014Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
207119 USD
CY2014Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
351403 USD
CY2014Q1 us-gaap Assets Current
AssetsCurrent
8758661 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
9956268 USD
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8593455 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6050203 USD
CY2014Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
672093 USD
CY2014Q1 us-gaap Assets
Assets
18024209 USD
CY2014Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
778548 USD
CY2014Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2443695 USD
CY2014Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
1314221 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
1314221 USD
CY2014Q1 us-gaap Liabilities
Liabilities
5589407 USD
CY2013Q4 us-gaap Liabilities
Liabilities
4272691 USD
CY2014Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q1 us-gaap Common Stock Value
CommonStockValue
29956 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
29910 USD
CY2014Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
29088238 USD
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
28888712 USD
CY2014Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6601603 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6559708 USD
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
12434802 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
12277125 USD
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18024209 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16549816 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
543345 USD
CY2013Q4 us-gaap Assets
Assets
16549816 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
510550 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2447920 USD
CY2014Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.005
CY2014Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
872521 shares
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
872521 shares
CY2014Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
148605 USD
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
144921 USD
CY2014Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.005
CY2014Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.005
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.005
CY2014Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5991945 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5981896 shares
CY2014Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
0 shares
CY2014Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
668130 shares
CY2013Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
668130 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
176950 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0 shares
CY2014Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
40900 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
136050 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.04
CY2014Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2014Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
12.84
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.40
CY2014Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y2M12D
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
371000 USD
CY2014Q1 pmd Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Unamortized Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsUnamortizedFairValue
905000 USD
CY2014Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
456606 shares
CY2013Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
6432442 USD
CY2014Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
7044821 USD
CY2013Q1 us-gaap Cost Of Services
CostOfServices
2945171 USD
CY2014Q1 us-gaap Cost Of Services
CostOfServices
3249039 USD
CY2013Q1 us-gaap Gross Profit
GrossProfit
3487271 USD
CY2014Q1 us-gaap Gross Profit
GrossProfit
3795782 USD
CY2013Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
993711 USD
CY2014Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1184147 USD
CY2014Q1 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
16000 sqft
CY2013Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1126658 USD
CY2014Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1098600 USD
CY2013Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
164710 USD
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
344983 USD
CY2013Q1 us-gaap Operating Expenses
OperatingExpenses
2285079 USD
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
2627730 USD
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1202192 USD
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1168052 USD
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
471260 USD
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
413442 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
822345 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
756159 USD
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2014Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2013Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
CY2014Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5272647 shares
CY2014Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5317836 shares
CY2013Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5292686 shares
CY2014Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5371418 shares
CY2013Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
207053 USD
CY2014Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
218019 USD
CY2013Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-42696 USD
CY2014Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-58608 USD
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
152008 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
449799 USD
CY2013Q1 pmd Increase Decrease In Prepaid Expenses And Other Current Assets
IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets
-322639 USD
CY2014Q1 pmd Increase Decrease In Prepaid Expenses And Other Current Assets
IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets
55710 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
267998 USD
CY2013Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-639936 USD
CY2014Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1088173 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-376479 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1806071 USD
CY2013Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
790865 USD
CY2014Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
798054 USD
CY2013Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
0 USD
CY2014Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
1083948 USD
CY2014Q1 dei Document Type
DocumentType
10-Q
CY2014Q1 dei Amendment Flag
AmendmentFlag
false
CY2014Q1 dei Document Period End Date
DocumentPeriodEndDate
2014-03-31
CY2014Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2014Q1 dei Trading Symbol
TradingSymbol
PMD
CY2014Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5323015 shares
CY2014Q1 dei Entity Registrant Name
EntityRegistrantName
PSYCHEMEDICS CORP
CY2014Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000806517
CY2014Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2014Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2014Q1 pmd Lease Expiration Term
LeaseExpirationTerm
three years
CY2014Q1 pmd Lease Extended Term
LeaseExtendedTerm
two additional years
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
136050 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
0 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
14.40
CY2014Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y2M12D
CY2014Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
371000 USD
CY2014Q1 pmd Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Unamortized Fair Value Period For Amortization
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsUnamortizedFairValuePeriodForAmortization
P2Y7M6D
CY2013Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
20000 shares
CY2014Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
53000 shares
CY2013Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
200000 shares
CY2013Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
152510 USD
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1524432 USD
CY2013Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
180108 USD
CY2014Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
147192 USD
CY2013Q1 pmd Payments For Proceeds From Sale Of Other Assets
PaymentsForProceedsFromSaleOfOtherAssets
43861 USD
CY2014Q1 pmd Payments For Proceeds From Sale Of Other Assets
PaymentsForProceedsFromSaleOfOtherAssets
134447 USD
CY2013Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
5323 USD
CY2014Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
47564 USD
CY2014Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5368057 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5175722 USD
CY2014Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
210589 USD
CY2013Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2014Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
842354 USD
CY2013Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 USD
CY2013Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
CY2014Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1052943 USD
CY2014Q1 us-gaap Long Term Debt And Capital Lease Obligations Repayments Of Principal In Next Twelve Months
LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths
158000 USD
CY2014Q1 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Two
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo
211000 USD
CY2014Q1 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Three
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree
211000 USD
CY2014Q1 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Four
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour
211000 USD
CY2014Q1 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Five
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive
210000 USD
CY2014Q1 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal After Year Five
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive
52000 USD
CY2014Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
1053000 USD
CY2014Q1 us-gaap Debt Instrument Unused Borrowing Capacity Amount
DebtInstrumentUnusedBorrowingCapacityAmount
1052943 USD
CY2014Q1 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.0215 pure

Files In Submission

Name View Source Status
0001144204-14-026766-index-headers.html Edgar Link pending
0001144204-14-026766-index.html Edgar Link pending
0001144204-14-026766.txt Edgar Link pending
0001144204-14-026766-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
pmd-20140331.xml Edgar Link completed
pmd-20140331.xsd Edgar Link pending
pmd-20140331_cal.xml Edgar Link unprocessable
pmd-20140331_def.xml Edgar Link unprocessable
pmd-20140331_lab.xml Edgar Link unprocessable
pmd-20140331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tlogo01.jpg Edgar Link pending
tlogo02.jpg Edgar Link pending
tsign1.jpg Edgar Link pending
tsign2.jpg Edgar Link pending
v375219_10q.htm Edgar Link pending
v375219_ex10-1.htm Edgar Link pending
v375219_ex10-2.htm Edgar Link pending
v375219_ex10-3.htm Edgar Link pending
v375219_ex31-1.htm Edgar Link pending
v375219_ex31-2.htm Edgar Link pending
v375219_ex32-1.htm Edgar Link pending
v375219_ex32-2.htm Edgar Link pending